What are the possible etiologies of multiple ischemic strokes in a young adult (<45 years)?

Causes of Multiple Ischemic Strokes in Young Patients

In young adults under 45 with multiple ischemic strokes, you must systematically investigate arteriopathies (especially dissection and moyamoya), cardiac sources (particularly patent foramen ovale with paradoxical embolism), hypercoagulable states (antiphospholipid syndrome, inherited thrombophilias), and less common etiologies like vasculitis and drug-related causes.

Arteriopathies - The Leading Culprit

Arteriopathies account for 18-64% of pediatric and young adult ischemic strokes and carry a 66% recurrence risk 1. These are your highest-yield investigations:

Arterial Dissection

• Accounts for 15-20% of young stroke cases 2
• Cervical artery dissections (carotid and vertebral) are particularly common in young patients 3
• Often occurs spontaneously or after trivial trauma
• Associated with underlying connective tissue disorders: fibromuscular dysplasia, Marfan syndrome, Ehlers-Danlos type IV, osteogenesis imperfecta 3
• Mechanism: thromboembolism from the dissection site
• Imaging priority: MRI/MRA with fat saturation protocols or CTA of head and neck 1

Moyamoya Disease/Syndrome

• Accounts for 6% of childhood strokes and 22% of arteriopathies 1, 2
• Progressive stenosis of distal internal carotid artery and proximal circle of Willis vessels with characteristic collateral formation
• Multiple and recurrent strokes are the hallmark presentation in children, typically in watershed territories 4
• Familial incidence of 7-12% in first-degree relatives 4
• Associated conditions: sickle cell disease (up to 40% show moyamoya-like changes), Down syndrome, neurofibromatosis type 1, history of cranial radiotherapy 4
• Ethnicity matters: 4.6-fold higher in Asian Americans, 2.2-fold in Blacks compared to whites 4

Other Arteriopathies

• Reversible cerebral vasoconstriction syndrome
• Vasculitis (12% of cases) 2
• Genetic mutations (ACTA2, CERC1 genes) 1

Cardiac Sources - Especially with Paradoxical Embolism

Cardioembolism increases at recurrence (10.7% at first stroke vs 18.0% at recurrence) 5.

Patent Foramen Ovale (PFO)

• Critical in young patients, particularly when combined with hypercoagulable states
• The prothrombin G20210A mutation (not Factor V Leiden) is significantly more common in young stroke patients (<45 years) with PFO, suggesting susceptibility to paradoxical embolism 6
• PFO closure may be considered for recurrent cryptogenic stroke despite optimal medical therapy (Class IIb) 6
• Echocardiography is essential - both transthoracic and transesophageal to detect PFO and other cardiac sources 7

Other Cardiac Sources

• Atrial myxoma, dilated cardiomyopathy, intracardiac thrombus (high-risk sources)
• Atrial septal defect, nonbacterial thrombotic endocarditis, left ventricular hypokinesis (medium-risk sources) 2

Hypercoagulable States - Test Selectively

Antiphospholipid Syndrome

• Most clinically relevant hypercoagulable state in young adults
• Prevalence 1-6.5% in general population, higher in young stroke patients
• Association strongest in those <50 years 6
• Testing recommended in cryptogenic stroke, especially with PFO

Inherited Thrombophilias

The evidence is nuanced and somewhat contradictory:

• These rarely contribute to adult arterial stroke but may play a larger role in pediatric/young adult stroke 3, 6
• Factor V Leiden: Weak association (OR 1.33), stronger in young (<55 years) 6
• Prothrombin G20210A mutation: Modest association (OR 1.44), particularly in cryptogenic stroke patients <50 years (OR 3.75) and when combined with PFO 6
• MTHFR C677T: Weak association (OR 1.24-1.26) 6
• Protein C, protein S, antithrombin III deficiency: More relevant for venous thromboembolism and pediatric stroke 6

Key clinical point: The mechanism is likely paradoxical embolism from venous thrombosis rather than direct arterial thrombosis 3, 8. Therefore, evaluate for deep vein thrombosis when inherited thrombophilia is found 6.

Guideline Recommendations for Thrombophilia

• Test when there's evidence of venous thrombosis or recurrent thrombotic events
• If inherited thrombophilia found without venous thrombosis: antiplatelet therapy is reasonable; anticoagulation may be considered for recurrent events (Class IIa-IIb) 6
• Presence of venous thrombosis mandates anticoagulation 6

Other Determined Etiologies

These account for 39.8% of strokes in the 18-40 age group 7:

Hematologic Disorders

• Sickle cell disease arteriopathy (8% of cases) 2
• Protein S deficiency
• Cerebral venous thrombosis 2

Drug-Related

• Increasingly recognized cause
• Sympathomimetics, cocaine, amphetamines

Hyperhomocysteinemia

• 2-fold greater stroke risk
• Recommendation: Daily multivitamin with B6 (1.7 mg), B12 (2.4 µg), folate (400 µg) for levels >10 µmol/L (Class IIa), though no proven benefit for stroke recurrence 6

Critical Diagnostic Algorithm

1. Immediate vascular imaging: CTA or MRA of head and neck - highest yield (80.3% positive results) 7
2. Cardiac evaluation: Echocardiography (transthoracic ± transesophageal) for all young stroke patients
3. Hypercoagulability testing: Focus on antiphospholipid antibodies; consider inherited thrombophilias in cryptogenic cases, especially with PFO
4. Extended cardiac monitoring: >24 hours for suspected embolic stroke 9
5. Consider genetic/metabolic testing in highly selected cases with family history or syndromic features

Common Pitfalls to Avoid

• Don't assume traditional risk factors are absent: Diabetes (24.5%) and dyslipidemia (54.3%) are common even in the 41-50 age group 7, 2
• Don't over-interpret inherited thrombophilias: Their role in arterial stroke is controversial; focus on whether venous thrombosis is present
• Don't miss dissection: Requires specific imaging protocols (fat saturation MRI or CTA)
• Don't forget bilateral imaging: Moyamoya is bilateral by definition, though may be asymmetric
• Don't neglect lifestyle factors: Smoking, alcohol, and obesity are more prevalent in young stroke patients 2

The proportion of cryptogenic strokes decreases with thorough investigation (16.7% at first stroke to 6.7% at recurrence using TOAST criteria) 5, emphasizing the importance of comprehensive workup in this population.